Patents by Inventor Anne Gatignol

Anne Gatignol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense-based small RNA agents targeting the Gag open reading frame of HIV-1 RNA
    Patent number: 9932364
    Abstract: Antisense nucleic acid molecules, such as ribozymes, shRNA and siRNA, targeting the Gag region of HIV-1 open reading frame, and uses thereof for inhibiting HIV-1 replication and infection, are disclosed. The antisense nucleic acid molecules more specifically target a sequence corresponding to about nucleotide 1495 to about nucleotide 1526, or nucleotide 1497 to about nucleotide 1521, of HIV-1 clone pNL4-3.
    Type: Grant
    Filed: August 25, 2014
    Date of Patent: April 3, 2018
    Assignee: The Royal Institution for the Advancement of Learning/McGill University
    Inventors: Anne Gatignol, Robert Scarborough
  • ANTISENSE-BASED SMALL RNA AGENTS TARGETING THE GAG OPEN READING FRAME OF HIV-1 RNA
    Publication number: 20160201061
    Abstract: Antisense nucleic acid molecules, such as ribozymes, shRNA and siRNA, targeting the Gag region of HIV-1 open reading frame, and uses thereof for inhibiting HIV-1 replication and infection, are disclosed. The antisense nucleic acid molecules more specifically target a sequence corresponding to about nucleotide 1495 to about nucleotide 1526, or nucleotide 1497 to about nucleotide 1521, of HIV-1 clone pNL4-3.
    Type: Application
    Filed: August 25, 2014
    Publication date: July 14, 2016
    Inventors: Anne Gatignol, Robert Scarborough